Harga Saham & Berita Precigen Inc (PGEN)

Symbols Symbols	Price	Change	% Change	Trend	Prev Close	Buka	High	Low	Volume	Mkt Cap
SIXB Materials SIXB Materials	SIXB -0.21%	1,091.51	-2.30	-0.21%	—	1,093.81	1,096.52	1,100.22	1,091.51	—	—
SIXC Communications SIXC Communications	SIXC +0.22%	610.11	+1.34	+0.22%	—	608.77	608.77	612.97	608.77	—	—
SIXE Energy SIXE Energy	SIXE -1.34%	1,237.98	-16.83	-1.34%	—	1,254.81	1,253.01	1,253.87	1,226.33	—	—
SIXI Industrials SIXI Industrials	SIXI -0.93%	1,744.71	-16.40	-0.93%	—	1,761.11	1,764.27	1,766.88	1,744.71	—	—
SIXM Financials SIXM Financials	SIXM -0.37%	640.18	-2.40	-0.37%	—	642.58	644.87	648.48	640.18	—	—
SIXR Staples SIXR Staples	SIXR -0.18%	849.58	-1.55	-0.18%	—	851.13	855.66	858.75	845.56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0.23%	217.48	-0.50	-0.23%	—	217.98	217.98	218.65	216.88	—	—
SIXT Technology SIXT Technology	SIXT +1.52%	3,260.69	+48.86	+1.52%	—	3,211.83	3,227.21	3,268.38	3,226.55	—	—
SIXU Utilities SIXU Utilities	SIXU -0.69%	942.45	-6.53	-0.69%	—	948.98	948.58	957.83	941.97	—	—
SIXV Health care SIXV Health care	SIXV -0.52%	1,466.80	-7.72	-0.52%	—	1,474.52	1,479.03	1,481.04	1,466.80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0.22%	2,397.50	+5.38	+0.22%	—	2,392.12	2,396.95	2,421.22	2,382.32	—	—

PGEN:NASDAQ

Precigen Inc

USD 4.08

-1.92%

(-0.080) 1H

USD 4.07

-0.25% (-0.0100)

Selepas waktu pejabat

Ditutup: 1 Mei, 4:00:00 PTG GMT-4 · USD

Semua simbol

TSS

MAKS

	Simbol	Price	Change	% Change

Generating top insights for PGEN...

Buka

USD 4.13

High

USD 4.18

Low

USD 4.06

Mkt. cap

1.44B

Avg. vol.

4.77J

Volume

1.76J

52-wk high

USD 5.46

52-wk low

USD 1.22

EPS

-USD 1.37

Beta

1.12

Shares outstanding

353.93J

No. of employees

160

Related stocks

BCRX

BioCryst Pharmaceuticals Inc

Sangamo Therapeutics Inc

News stories

From sources across the web

Newser

1 minggu lalu

PGEN (Precigen) beats Q4 2025 EPS expectations, posts 146.7 percent revenue growth as shares rise 3.27 percent. - ADR

Newser

1 minggu lalu

PGEN (Precigen Inc.) reports narrower Q4 2025 loss than estimates, shares rise slightly on positive investor sentiment. - Direct Listing

Profil

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia

About Precigen Inc

CEOHelen Sabzevari

Employees160

Founded21 Mei 1998

Headquarters-

Sector-

Websiteprecigen.com

All values in USD	Mac 2025	Jun 2025	Sep 2025	Dis 2025
Revenue	1.34J	856.00K	2.92J	4.56J
Cost of goods sold	1.10J	1.56J	13.41J	8.59J
Cost of revenue	1.10J	1.56J	13.41J	8.59J
Research and development expenses	10.48J	11.02J	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12.36J	16.13J	23.99J	17.64J
Operating expense	22.84J	27.16J	23.99J	17.64J
Total operating expenses	23.94J	28.71J	37.40J	26.23J
Operating income	-22.60J	-27.86J	-34.48J	-21.67J
Other non operating income	-32.47J	4.43J	-111.50J	60.00K
EBT including unusual items	-54.15J	-26.64J	-146.34J	-23.50J
EBT excluding unusual items	-54.15J	-22.73J	-146.34J	-23.50J
Income tax expense	-	3.00K	-	-
Effective tax rate	-	-0.01%	-	-
Other operating expenses	-	-	-	-
Net income	-54.15J	-26.64J	-146.34J	-23.50J
Net profit margin	-4,038.26%	-3,112.38%	-5,008.35%	-514.85%
Earnings per share	-0.18	-0.08	-	-
Interest and investment income	918.00K	696.00K	534.00K	1.07J
Interest expense	-1.00K	-	-902.00K	-2.96J
Net interest expenses	917.00K	696.00K	-368.00K	-1.90J
Depreciation and amortization charges	-	-	-	-
EBITDA	-21.97J	-27.23J	-33.68J	-20.53J
Gain or loss from assets sale	-	14.00K	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research